<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00123136</url>
  </required_header>
  <id_info>
    <org_study_id>2005-81440-DPN</org_study_id>
    <nct_id>NCT00123136</nct_id>
  </id_info>
  <brief_title>Bi-Axial Rotating Magnetic Field Therapy in Refractory Neuropathic Foot Pain Secondary to Diabetic Peripheral Neuropathy</brief_title>
  <official_title>Bi-Axial Rotating Magnetic Field Therapy in Refractory Neuropathic Foot Pain Secondary to Diabetic Peripheral Neuropathy. Multi-Center, Randomized Placebo Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Weintraub, Michael I., MD, FACP, FAAN</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Nu-Magnetics Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Weintraub, Michael I., MD, FACP, FAAN</source>
  <brief_summary>
    <textblock>
      The researchers will study the application of a commercial pulsed magnetic stimulating device
      to the feet of patients with moderate-severe foot pain secondary to diabetic peripheral
      neuropathy (DPN).
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>August 2005</start_date>
  <completion_date>December 2006</completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double</masking>
  </study_design_info>
  <primary_outcome>
    <measure>reduction of neuropathic foot pain</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>improve quality of life</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>serial changes in EDX, QST, autonomic functions, biopsy</measure>
  </secondary_outcome>
  <enrollment>250</enrollment>
  <condition>Diabetic Neuropathies</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>foot energizer</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  DPN stage 2 and 3; symptomatic &gt; 6 months

        Exclusion Criteria:

          -  Pacemaker in patient or mate
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael Weintraub, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>New York Medical College</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Michael I. Weintraub, MD</last_name>
    <phone>914-941-0788</phone>
    <email>miwneuro@pol.net</email>
  </overall_contact>
  <location>
    <facility>
      <name>Michael I. Weintraub MD 325 S. Highland Avenue</name>
      <address>
        <city>Briarcliff</city>
        <state>New York</state>
        <zip>10510</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Susan Wolert, Data</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2006</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 20, 2005</study_first_submitted>
  <study_first_submitted_qc>July 20, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 22, 2005</study_first_posted>
  <last_update_submitted>June 28, 2006</last_update_submitted>
  <last_update_submitted_qc>June 28, 2006</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 4, 2006</last_update_posted>
  <keyword>pulsed magnetic field therapy</keyword>
  <keyword>diabetic peripheral neuropathy</keyword>
  <keyword>neuromodulation</keyword>
  <keyword>diabetic peripheral neuropathic pain</keyword>
  <keyword>sleep benefit</keyword>
  <keyword>diabetic peripheral neuropathic functioning</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Peripheral Nervous System Diseases</mesh_term>
    <mesh_term>Diabetic Neuropathies</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

